​

Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?

OverviewForecastFinancialsChart

Rocket Pharmaceuticals Ownership Summary

Rocket Pharmaceuticals is owned by 97.90% institutional investors, 2.74% insiders. Rtw investments, lp is the largest institutional shareholder, holding 18.87% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.11% of its assets in Rocket Pharmaceuticals shares.

RCKT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRocket Pharmaceuticals97.90%2.74%-0.64%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp17.69M18.87%$380.82M
Wellington management group llp14.00M14.86%$175.92M
Blackrock funding, inc. /de7.10M7.54%$89.21M
Vanguard group6.58M6.99%$82.68M
Blackrock6.19M6.61%$133.33M
Maverick capital5.20M5.52%$65.35M
Westfield capital management co lp4.71M5.01%$59.26M
Janus henderson group4.00M4.25%$50.34M
Price t rowe associates inc /md/3.15M3.34%$39.58M
State street2.78M2.97%$59.85M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rtw investments, lp17.69M5.90%$380.82M
M28 capital management lp385.68K4.76%$4.85M
New leaf venture partners150.71K2.53%$1.89M
Bioimpact capital1.02M1.82%$12.83M
Acuta capital partners134.50K1.70%$1.69M
Boxer capital1.47M1.66%$31.56M
Frazier life sciences management1.56M1.57%$33.61M
Privium fund management b.v.250.98K1.27%$4.96M
Maverick capital5.20M1.18%$65.35M
Suvretta capital management2.57M1.10%$32.27M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp14.00M0.03%2.75M
Suvretta capital management2.57M1.10%2.57M
Janus henderson group4.00M0.03%2.11M
Toronto dominion bank1.10M0.02%1.10M
Maverick capital5.20M1.18%1.08M

Top Sellers

HolderShares% AssetsChange
Point72 asset management---1.57M
State street2.78M0.00%-1.41M
Avoro capital advisors---1.20M
Franklin resources653.56K0.00%-1.08M
Avidity partners management lp---1.05M

New Positions

HolderShares% AssetsChangeValue
Suvretta capital management2.57M1.10%2.57M$32.27M
Toronto dominion bank1.10M0.02%1.10M$13.83M
Siren600.00K0.33%600.00K$7.54M
Voss capital421.70K0.39%421.70K$5.30M
Baker bros. advisors lp97.08K0.01%97.08K$1.22M

Sold Out

HolderChange
Allspring global investments-20.00
Evermay wealth management-25.00
Innealta capital-49.00
Mrp capital investments-50.00
Lazard asset management-78.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252465.58%107,782,550-1.70%970.72%1604.58%43-6.52%
Dec 31, 20242158.59%85,361,633-7.77%900.94%14044.33%43-20.37%
Sep 30, 20241987.03%92,550,2191.43%981.04%97-2.02%5410.20%
Jun 30, 2024185-7.04%91,245,649-1.15%971.00%9911.24%49-23.44%
Mar 31, 2024199-4.78%92,305,1103.71%981.09%89-15.24%64-5.88%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Health Care Inv7.60M7.11%-
Vanguard Total Stock Mkt Idx Inv2.77M2.59%146.50K
RTW Biotech Opportunities Ord2.40M2.25%-
Vanguard US Total Market Shares ETF2.21M2.08%-245.50K
iShares Russell 2000 ETF1.98M1.84%972.00
SPDR® S&P Biotech ETF1.76M1.63%2.27K
Vanguard Institutional Extnd Mkt Idx Tr1.33M1.25%3.20K
Westfield Capital Mgt Co Sm-Cap Gr Eq1.23M1.16%22.76K
Harbor Small Cap Growth Instl1.23M1.16%-
Vanguard Small Cap Index1.04M0.98%1.23K

Recent Insider Transactions

DateNameRoleActivityValue
May 20, 2025Militello John See RemarksSell$2.30K
May 20, 2025Schwartz Jonathan David See RemarksSell$5.16K
May 20, 2025Patel Kinnari See RemarksSell$4.94K
May 20, 2025Shah Gaurav CEOSell$14.52K
May 20, 2025Wilson Martin General CounselSell$3.78K

Insider Transactions Trends

DateBuySell
2025 Q2212
2025 Q1-6
2024 Q3-6
2024 Q2-9
2024 Q1-9

RCKT Ownership FAQ

Who Owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals shareholders are primarily institutional investors at 97.90%, followed by 2.74% insiders and -0.64% retail investors. The average institutional ownership in Rocket Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Rocket Pharmaceuticals exceeds.

Who owns the most shares of Rocket Pharmaceuticals?

Rocket Pharmaceuticals’s largest shareholders are Rtw investments, lp (17.69M shares, 18.87%), Wellington management group llp (14M shares, 14.86%), and Blackrock funding, inc. /de (7.1M shares, 7.54%). Together, they hold 41.27% of Rocket Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rocket Pharmaceuticals?

Yes, BlackRock owns 6.61% of Rocket Pharmaceuticals, totaling 6.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 133.33M$. In the last quarter, BlackRock increased its holdings by 262.72K shares, a 4.43% change.

Who is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Rtw investments, lp is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.90% of its assets in 17.69M Rocket Pharmaceuticals shares, valued at 380.82M$.

Who is the top mutual fund holder of Rocket Pharmaceuticals shares?

Vanguard Health Care Inv is the top mutual fund holder of Rocket Pharmaceuticals shares, with 7.11% of its total shares outstanding invested in 7.6M Rocket Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools